Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.53 |
| ▸ | ESR2 | Q92731 | 7/20 | 0.53 |
| ▸ | BACE1 | P56817 | 2/20 | 0.45 |
| ▸ | ESR1 | P03372 | 7/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | PELI1 | Q96FA3 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MPI | P34949 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.41 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.41 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.40 |
| ▸ | MIF | P14174 | 2/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29978461 | 1.00 | ALOX5 (0.53) | ALOX5ESR2BACE1ESR1ALDH1A1 | |
| SCHEMBL28033026 | 0.90 | ESR1 (0.47) | ALOX5ESR2ESR1ALDH1A1CYP3A4 | |
| SCHEMBL8994507 | 0.85 | ALOX5 (0.59) | ALOX5ESR2BACE1ESR1ALDH1A1 | |
| SCHEMBL19312137 | 0.83 | ESR2 (0.49) | ALOX5ESR2ESR1ALDH1A1CYP3A4 | |
| SCHEMBL728278 | 0.79 | CNR1 (0.42) | ESR2ESR1ALDH1A1CYP3A4HPGD | |
| SCHEMBL28526907 | 0.77 | ALOX5 (0.59) | ALOX5ESR2BACE1ESR1ALDH1A1 | |
| SCHEMBL30753562 | 0.77 | ALOX5 (0.59) | ALOX5ESR2BACE1ESR1ALDH1A1 | |
| SCHEMBL344517 | 0.76 | ABL1 (0.50) | ALOX5ESR2BACE1ESR1ALDH1A1 | |
| SCHEMBL30194426 | 0.76 | HSD17B1 (0.47) | ESR2ESR1CYP3A4HSD17B1HSD17B2 | |
| Ethane SCHEMBL6838808 | 0.75 | ALOX5 (0.68) | ALOX5ESR2BACE1ESR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132240-A1 | LINEAR BLOCK COPOLYMER AND CURABLE THERMOSETTING COMPOSITION COMPRISING THE LINEAR BLOCK COPOLYMER | SHPP GLOBAL TECH B V (NL) | 2026-05-14 | — | — | US | disclosed |
| EP-3636692-B1 | POLY(ARYLENE ETHER) COPOLYMER | SHPP GLOBAL TECH BV (NL) | 2026-04-29 | — | — | EP | disclosed |
| US-12503593-B2 | Curable thermosetting composition including poly(arylene ether) copolymer | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2025-12-23 | — | — | US | disclosed |
| WO-2025224628-A1 | POLYFUNCTIONAL POLY(ARYLENE ETHERS) AND CURABLE COMPOSITIONS THEREOF | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2025-10-30 | — | — | WO | disclosed |
| EP-3919545-B1 | CURABLE THERMOSETTING COMPOSITION INCLUDING POLY(ARYLENE ETHER) COPOLYMER | SHPP GLOBAL TECH BV (NL) | 2025-10-22 | — | — | EP | disclosed |
| EP-3885392-B1 | FUNCTIONALIZED POLY(ARYLENE ETHER) COPOLYMER, METHOD OF MAKING AND ARTICLES OBTAINED THEREFROM | SHPP GLOBAL TECH BV (NL) | 2025-07-02 | — | — | EP | disclosed |
| US-20250197542-A1 | COPOLYMERS DERIVED FROM DICYCLOPENTADIENE | SHPP GLOBAL TECH BV (NL) | 2025-06-19 | — | — | US | disclosed |
| US-20250163213-A1 | CURABLE RESIN, CURED PRODUCT THEREOF, AND RESIN COMPOSITION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-05-22 | — | — | US | disclosed |
| US-20250154315-A1 | METHOD FOR PRODUCING CURABLE RESIN | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-05-15 | — | — | US | disclosed |
| US-20250122328-A1 | COPOLYMERS DERIVED FROM DICYCLOPENTADIENE | SHPP GLOBAL TECNOLOGIES B V (NL) | 2025-04-17 | — | — | US | disclosed |
| US-20080142418-A1 | FUNCTIONAL POLYARYLETHERS | GENERAL ELECTRIC COMPANY (US) | 2008-06-19 | — | — | US | disclosed |
| US-20080142443-A1 | POLYARYLETHER MEMBRANES | GENERAL ELECTRIC (US) | 2008-06-19 | — | — | US | disclosed |
| US-20080142429-A1 | FUNCTIONAL POLYARYLETHERS | GENERAL ELECTRIC COMPANY (US) | 2008-06-19 | — | — | US | disclosed |
| WO-2008073537-A1 | FUNCTIONAL POLYARYLETERS | GENERAL ELECTRIC COMPANY (US) | 2008-06-19 | — | — | WO | disclosed |
| US-20080142442-A1 | hollow fiber modules comprising blends of polyphenylene ethers block polymers and polyvinylpyrrolidone, used for blood dialysis and filtration | GENERAL ELECTRIC (US) | 2008-06-19 | — | — | US | disclosed |
| WO-2008073532-A1 | POLYARYLETHER MEMBRANES | GENERAL ELECTRIC COMPANY (US) | 2008-06-19 | — | — | WO | disclosed |
| WO-2008073536-A1 | FUNCTIONAL POLYARYLETHERS | GENERAL ELECTRIC COMPANY (US) | 2008-06-19 | — | — | WO | disclosed |
| WO-2008036454-A1 | POLY (ARYLENE ETHER) COPOLYMER | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2008-03-27 | — | — | WO | disclosed |
| US-20050247913-A1 | Phosphorous ester compound, process for producing the same, and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-11-10 | — | — | US | disclosed |
| US-4260719-A | CYANOACRYLATE END GROUPS | GENERAL ELECTRIC COMPANY (US) | 1981-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080142429-A1 | FUNCTIONAL POLYARYLETHERS | CBR3, NR2E3, HRH4 | ALOX5 876/4885ESR2 810/4885BACE1 4437/4885 |
| US-20260132240-A1 | LINEAR BLOCK COPOLYMER AND CURABLE THERMOSETTING COMPOSITION COMPRISING THE LINEAR BLOCK COPOLYMER | CBLB, UBE4A, PSMD14 | ALOX5 193/4885ESR2 1490/4885BACE1 3361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.